Complement and coagulation cascades (WP558)
Homo sapiens
Blood coagulation is a series of coordinated and calcium-dependent proenzyme-to-serine protease conversions likely to be localized on the surfaces of activated cells in vivo. It culminates in the formation of thrombin, the enzyme responsible for the conversion of soluble fibrinogen to the insoluble fibrin clot. The kallikrein-kinin system is an endogenous metabolic cascade, triggering of which results in the release of vasoactive kinins (bradykinin-related peptides). Kinin peptides are implicated in many physiological and pathological processes including the regulation of blood pressure and sodium homeostasis, inflammatory processes, and the cardioprotective effects of preconditioning. Complement is a system of plasma proteins that is activated by the presence of pathogens. There are three pathways of complement activation: the classical pathway, the lectin pathway, and the alternative pathway. All of these pathways generate a crucial enzymatic activity that, intern, generates the effector molecules of complement. The three main consequences of complement activation are the opsonization of pathogens, the recruitment of inflammatory and immunocompetent cells, and the direct killing of pathogens. Source: KEGG Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP558 CPTAC Assay Portal]
Authors
Thomas Kelder , Kristina Hanspers , Luis , Alex Pico , Daniela Digles , Zahra Roudbari , Egon Willighagen , Linda Rieswijk , Friederike Ehrhart , Denise Slenter , Eric Weitz , and Finterly HuActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
- Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate (2022).
- Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients (2022).
- Novel ACE2 protein interactions relevant to COVID-19 predicted by evolutionary rate correlations (2021).
- Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2 (2020).
- Proteomic analysis of heart failure hospitalization among patients with chronic kidney disease: The Heart and Soul Study (2018).
- A proteomic signature that reflects pancreatic beta-cell function (2018).
- Saliva Proteomics Analysis Offers Insights on Type 1 Diabetes Pathology in a Pediatric Population (2018).
- Long Term Culture of the A549 Cancer Cell Line Promotes Multilamellar Body Formation and Differentiation towards an Alveolar Type II Pneumocyte Phenotype (2016).
- Acute and chronic blood serum proteome changes in patients with methanol poisoning (2022).
- Discovering Common Pathogenic Mechanisms of COVID-19 and Parkinson Disease: An Integrated Bioinformatics Analysis (2022).
- Investigation of the relationship between COVID-19 and pancreatic cancer using bioinformatics and systems biology approaches (2024).
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
Annotations
Pathway Ontology
complement system pathwayLabel | Type | Compact URI | Comment |
---|---|---|---|
Fibrin monomer | Metabolite | cas:9001-31-4 | |
Bradykinin | Metabolite | cas:58-82-2 | |
C2 | GeneProduct | ncbigene:717 | |
PLAT | GeneProduct | ncbigene:5327 | |
ADN | GeneProduct | ncbigene:1675 | |
F8 | GeneProduct | ncbigene:2157 | |
SERPINA5 | GeneProduct | ncbigene:5104 | |
F9 | GeneProduct | ncbigene:2158 | |
F2R | GeneProduct | ncbigene:2149 | |
CLU | GeneProduct | ncbigene:1191 | CLU |
SERPINA1 | GeneProduct | ncbigene:5265 | |
TFPI | GeneProduct | ncbigene:7035 | |
CFH | GeneProduct | ncbigene:3075 | |
FGB | GeneProduct | ncbigene:2244 | |
KLKB1 | GeneProduct | ncbigene:3818 | |
MASP2 | GeneProduct | ncbigene:10747 | |
C5R1 | GeneProduct | ncbigene:728 | |
A2M | GeneProduct | ncbigene:2 | |
MCP | GeneProduct | ncbigene:4179 | |
F13B | GeneProduct | ncbigene:2165 | |
F10 | GeneProduct | ncbigene:2159 | |
F7 | GeneProduct | ncbigene:2155 | |
CR2 | GeneProduct | ncbigene:1380 | |
F3 | GeneProduct | ncbigene:2152 | |
SERPING1 | GeneProduct | ncbigene:710 | |
C1S | GeneProduct | ncbigene:716 | |
C1QG | GeneProduct | ncbigene:714 | |
BDKRB1 | GeneProduct | ncbigene:623 | |
C7 | GeneProduct | ncbigene:730 | MGI:88235 LL:109828 |
F5 | GeneProduct | ncbigene:2153 | |
VWF | GeneProduct | ncbigene:7450 | |
PLAU | GeneProduct | ncbigene:5328 | |
SERPINF2 | GeneProduct | ncbigene:5345 | |
C3AR1 | GeneProduct | ncbigene:719 | |
THBD | GeneProduct | ncbigene:7056 | |
Hc | GeneProduct | ncbigene:1213 | |
CFI | GeneProduct | ncbigene:3426 | |
F2 | GeneProduct | ncbigene:2147 | |
C1R | GeneProduct | ncbigene:715 | |
PROC | GeneProduct | ncbigene:5624 | |
Daf1 | GeneProduct | ncbigene:1604 | |
PROS1 | GeneProduct | ncbigene:5627 | |
PLAUR | GeneProduct | ncbigene:5329 | |
C1QB | GeneProduct | ncbigene:713 | |
SERPINE1 | GeneProduct | ncbigene:5054 | |
C6 | GeneProduct | ncbigene:729 | |
C1QA | GeneProduct | ncbigene:712 | |
C8G | GeneProduct | ncbigene:733 | |
F12 | GeneProduct | ncbigene:2161 | |
MBL1 | GeneProduct | ncbigene:3998 | |
C9 | GeneProduct | ncbigene:735 | |
SERPINC1 | GeneProduct | ncbigene:462 | |
109821 | GeneProduct | ncbigene:109821 | |
PLG | GeneProduct | ncbigene:5340 | |
SERPIND1 | GeneProduct | ncbigene:3053 | |
C3 | GeneProduct | ncbigene:718 | |
H2-BF | GeneProduct | ncbigene:629 | |
MASP1 | GeneProduct | ncbigene:5648 | |
CPB2 | GeneProduct | ncbigene:1361 | |
C4 | GeneProduct | ncbigene:721 | |
KNG1 | GeneProduct | ncbigene:3827 | |
CR1 | GeneProduct | ncbigene:1378 |
References
- KEGG Pathway: map04610